Credit Suisse’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q2 | – | Sell |
-32,156
| Closed | -$3.14M | – | 4361 |
|
|
2015
Q1 | $3.14M | Buy |
32,156
+6,382
| +25% | +$623K | ﹤0.01% | 1832 |
|
|
2014
Q4 | $2.39M | Buy |
25,774
+12,112
| +89% | +$1.12M | ﹤0.01% | 2099 |
|
|
2014
Q3 | $940K | Sell |
13,662
-4,759
| -26% | -$327K | ﹤0.01% | 2746 |
|
|
2014
Q2 | $1.93M | Sell |
18,421
-5,978
| -25% | -$627K | ﹤0.01% | 2385 |
|
|
2014
Q1 | $2.02M | Buy |
24,399
+7,726
| +46% | +$641K | ﹤0.01% | 2195 |
|
|
2013
Q4 | $1.08M | Buy |
16,673
+8,871
| +114% | +$574K | ﹤0.01% | 2823 |
|
|
2013
Q3 | $495K | Sell |
7,802
-21,654
| -74% | -$1.37M | ﹤0.01% | 3089 |
|
|
2013
Q2 | $1.24M | Buy |
+29,456
| New | +$1.24M | ﹤0.01% | 2285 |
|